![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.36 | -10.6194690265 | 3.39 | 3.54 | 2.92 | 525126 | 3.14571099 | CS |
4 | -0.15 | -4.71698113208 | 3.18 | 4.24 | 2.92 | 798028 | 3.55645084 | CS |
12 | -0.03 | -0.980392156863 | 3.06 | 4.64 | 2.7 | 1402340 | 3.54576509 | CS |
26 | -9.61 | -76.0284810127 | 12.64 | 16.55 | 2.7 | 1196285 | 7.19663316 | CS |
52 | -5.19 | -63.1386861314 | 8.22 | 19.05 | 2.7 | 2457603 | 12.28771062 | CS |
156 | -0.733 | -19.4791389849 | 3.763 | 19.05 | 2.05 | 1684510 | 10.40097964 | CS |
260 | -0.733 | -19.4791389849 | 3.763 | 19.05 | 2.05 | 1684510 | 10.40097964 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions